BB Biotech Semi Variance
| BION Stock | | | CHF 44.65 -0.45 -1.00% |
The Semi Variance lookup presents technical context for BB Biotech AG and related instruments. Availability can vary by instrument;
Equity Screeners offers additional screening access. BB Biotech has a market cap of 2.46 B, operating margin of 98.0%, ROE of 22.83%.
Trending Equities can help frame allocation decisions. The allocation includes a position in BB Biotech AG within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in inflation.
BB Biotech AG has current Semi Variance of 0. Semi-variance provides a good measure of downside volatility for equity or a portfolio. It is similar to variance, but it only looks at periods where the returns are less than the target or average level.
Semi Variance | = | SUM(RET DEV)2N(ZERO) |
| = | 0 | |
| SUM | = | Summation notation |
| RET DEV | = | Actual return deviation over selected period |
| N(ZERO) | = | Number of points with returns less than zero |
BB Biotech Semi Variance Peers Comparison
BION Semi Variance Relative To Other Indicators
BB Biotech AG is rated
below average for semi variance across the peer group. It is currently under evaluation for maximum drawdown across the peer group .
Semi-variance is the square of semi-deviation. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.